The Scientist

» cancer drugs

Most Recent

image: AbbVie Wins Bidding War for Cancer Drugmaker

AbbVie Wins Bidding War for Cancer Drugmaker

By | March 5, 2015

The pharmaceutical firm beat out a host of potential suitors, Johnson & Johnson among them, to strike a $21 billion deal with Pharmacyclics.

0 Comments

image: Lavish Spending at MD Anderson

Lavish Spending at MD Anderson

By | May 28, 2013

The public cancer center is criticized for allegedly devoting at least $1.5 million to remodeling an executive suite.

0 Comments

image: Spinning Clinical Trials

Spinning Clinical Trials

By | January 16, 2013

Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.

0 Comments

image: $18M Grant to Be Re-reviewed

$18M Grant to Be Re-reviewed

By | June 1, 2012

A Texas cancer institute is taking a second look at the largest grant it ever awarded after concerns were raised that the proposal never received proper scientific review.

5 Comments

image: Collecting Cancer Data

Collecting Cancer Data

By | March 29, 2012

Two new cancer cell line databases bursting with genomic and drug profiling data may help researchers identify drug targets.

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech